Purchase Order 75N98026P00453
Award Date 7/1/26
Potential Completion Date 6/30/27
Potential Value $58K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
India
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to GVK Biosciences Private Limited for $24,900.00 on August 18, 2017. The order procures chemical stability testing using simulated gastric and intestinal fluids, with work performed in India under firm fixed price terms. The order completion date is October 12, 2017.</p>
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Vanderbilt University for $15,799.25 on June 5, 2020, for animal testing, with completion by September 10, 2020. Performance occurs at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>
- The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...
- <p>The National Institute on Drug Abuse issued a purchase order to Labcorp Early Development Laboratories Inc. valued at $108,254.16 on July 1, 2023, for completion of pharmacokinetics for the MAD portion of the RR-HNK Phase 1 study under the FY26 UDO initiative. Work is performed in Madison, Wisconsin. The order carries a firm fixed price structure and was not set-aside. Ultimate completion date was June 30, 2025.</p>
- The National Institute on Drug Abuse awarded a purchase order to Pharmaron, Inc. for $62,550.25 on September 1, 2023, to conduct a maximally tolerated dose and 14-day dose range-finding toxicity study in male and female rats. Performance is in China. The study determines the maximum tolerability dose of a lead molecule and generates a written toxicity report. The contractor must maintain confidentiality, comply with the Public Health Service Policy on Humane Care and Use of Laboratory Animals,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed-price purchase order to Ingenious Targeting Laboratory Inc. for $21,889.00 on February 20, 2026. The awardee is a minority-owned, Asian-Pacific American owned, small disadvantaged business. Work is performed in Holbrook, New York. The purchase order covers custom conditional knockin mouse production (Gene ID: ENSEMBL:ENSMUSG00000000394) for biomedical research, with invoicing structured in three or four...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>